CellarisBio has rights to multiple patents protecting the Micro-Tag™ cell target engagement technology. This robust enzyme complementation technology is based on split-RNase, enabling multiple unprecedented applications.
The small 15 amino acid-long subunit of the reporter enzyme is linked to the target, while the large subunit is added externally to the reaction. The complemented enzyme cleaves the FRET substrate and releases the fluorescent signal. The level of signal is proportional to that of stabilization of the target by the tested ligand.
The level of fluorescence signal from Micro-Tag™ reporter cells is sensitive to the number of cells and level of expressed target protein.
MTH1 tested using Micro-Tag™ platform has temperature of aggregation (T-agg) of 55C. It engages S-Crizotinib with EC50 of 58nM
Leverage highly responsive system designed for your target. Choose from multiple target families - human or non-human.
Empower your drug discovery program with de novo discovery using DNA-Encoded Libraries (DELs) - all in the cell.
Enhance the breadth of your assays with highly sensitive cellular assays, from low nano-molar to high micro-molar levels.
Scale your drug discovery effort for success. Use our sensitive cell systems for discovery and validation of novel drug candidates.
Upgrade your drug discovery data with real-time cell target engagement data. Reveal in-cell kinetics of drug-target engagement.
Augment your drug discovery with the power of Artificial Intelligence. Tap into larger libraries and discover novel drug candidates.
Copyright © 2024 CellarisBio - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.